Level Four Advisory Services’s Immunic IMUX Stock Holding History

Level Four Advisory Services’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,078	Closed	-$5.75K	–	890
2025 Q4	$5.75K	Hold	1,078	–	–	﹤0.01%	842
2025 Q3	$9.5K	Hold	1,078	–	–	﹤0.01%	802
2025 Q2	$7.52K	Sell	1,078 -39	-3%	-$358	﹤0.01%	784
2025 Q1	$12.2K	Hold	1,117	–	–	﹤0.01%	752
2024 Q4	$11.2K	Hold	1,117	–	–	﹤0.01%	751
2024 Q3	$13.5K	Hold	1,117	–	–	﹤0.01%	762
2024 Q2	$12.4K	Sell	1,117 -61	-5%	-$758	﹤0.01%	738
2024 Q1	$17.7K	Hold	1,178	–	–	﹤0.01%	764
2023 Q4	$17.7K	Sell	1,178 -1	-0.1%	-$12	﹤0.01%	760
2023 Q3	$17.3K	Hold	1,179	–	–	﹤0.01%	735
2023 Q2	$29.6K	Hold	1,179	–	–	﹤0.01%	790
2023 Q1	$17.6K	Buy	+1,179	New	+$21.9K	﹤0.01%	750

Other funds holding IMUX

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Level Four Advisory Services's IMUX Position: Q1 2026 in Review

Level Four Advisory Services sold out of Immunic (IMUX) in Q1 2026, closing a stake of 1,078 shares — an estimated $5.75K sold.

Level Four Advisory Services first reported a position in IMUX in Q1 2023 and held it in 12 quarters. The position peaked at $29.6K in Q2 2023. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

Level Four Advisory Services reported no remaining Immunic position as of Q1 2026 after selling out during the quarter.
Level Four Advisory Services sold 1,078 Immunic shares in Q1 2026, an estimated $5.75K.
Level Four Advisory Services first reported a position in Immunic in Q1 2023 and held it in 12 quarters.
Level Four Advisory Services's Immunic position peaked at $29.6K in Q2 2023.
75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Level Four Advisory Services's 13F filing for Q1 2026, filed 14 May 2026.